DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis
Authors
Keywords
CXCL8, DACH1, Lung cancer, Progression, Prognosis, AP-1, NF-κB
Journal
Journal of Hematology & Oncology
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-19
DOI
10.1186/s13045-018-0597-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue
- (2017) Gang Liu et al. Journal of Hematology & Oncology
- AC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways
- (2017) Yi-Hua Lai et al. Journal of Hematology & Oncology
- Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer
- (2017) Xiaoxue Zhang et al. Journal of Hematology & Oncology
- Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment
- (2017) Qian Liu et al. TUMOR BIOLOGY
- The clinical significance of CXCL5 in non-small cell lung cancer
- (2017) Kongju Wu et al. OncoTargets and Therapy
- The CXCL8-CXCR1/2 pathways in cancer
- (2016) Qian Liu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
- (2016) Hanxiao Xu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The expression profile and clinic significance of the SIX family in non-small cell lung cancer
- (2016) Qian Liu et al. Journal of Hematology & Oncology
- Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NFκB-TLR signaling pathway
- (2016) Xiaoxia Li et al. Journal of Hematology & Oncology
- Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer
- (2016) Yijun Tian et al. Journal of Hematology & Oncology
- DACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3
- (2016) Ji Zhu et al. TUMOR BIOLOGY
- The Endogenous Cell-Fate Factor Dachshund Restrains Prostate Epithelial Cell Migration via Repression of Cytokine Secretion via a CXCL Signaling Module
- (2015) K. Chen et al. CANCER RESEARCH
- The DACH/EYA/SIX gene network and its role in tumor initiation and progression
- (2015) Yu Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancer
- (2015) Alba Dalmases et al. Oncotarget
- Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma
- (2014) N Sunaga et al. BRITISH JOURNAL OF CANCER
- DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells
- (2014) Qian Chu et al. Journal of Hematology & Oncology
- Dachshund Binds p53 to Block the Growth of Lung Adenocarcinoma Cells
- (2013) K. Chen et al. CANCER RESEARCH
- Autocrine IL-8 and VEGF mediate epithelial–mesenchymal transition and invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer cells
- (2013) Sejal Desai et al. CELLULAR SIGNALLING
- A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non-Small Cell Lung Cancer Patients
- (2013) H. Tang et al. CLINICAL CANCER RESEARCH
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
- (2012) Ramaswamy Govindan et al. CELL
- Biomarker Discovery in Non-Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
- (2012) J. Botling et al. CLINICAL CANCER RESEARCH
- Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression
- (2012) S. A. Selamat et al. GENOME RESEARCH
- Identification of a Novel Biomarker, SEMA5A, for Non-Small Cell Lung Carcinoma in Nonsmoking Women
- (2010) T.-P. Lu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cell Fate Determination Factor Dachshund Reprograms Breast Cancer Stem Cell Function
- (2010) Kongming Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Attenuation of Forkhead signaling by the retinal determination factor DACH1
- (2010) J. Zhou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Cell Fate Determination Factor Dachshund Inhibits Androgen Receptor Signaling and Prostate Cancer Cellular Growth
- (2009) K. Wu et al. CANCER RESEARCH
- The Cell Fate Determination Factor DACH1 Is Expressed in Estrogen Receptor- -Positive Breast Cancer and Represses Estrogen Receptor- Signaling
- (2009) V. M. Popov et al. CANCER RESEARCH
- Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis
- (2009) Shuta Tomida et al. JOURNAL OF CLINICAL ONCOLOGY
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival
- (2008) Maria Teresa Landi et al. PLoS One
- Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8
- (2008) K. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started